Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells

por Ager, Ann, Watson, H. Angharad, Wehenkel, Sophie C., Mohammed, Rebar N.
Publicado 2016

L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity

por Mohammed, Rebar N., Watson, H. Angharad, Vigar, Miriam, Ohme, Julia, Thomson, Amanda, Humphreys, Ian R., Ager, Ann
Publicado 2016

The Effects of Smoking on IgE, Oxidative Stress and Haemoglobin Concentration

por Ahmed, Najat J, Husen, Adnan Z, Khoshnaw, Najmaddin, Getta, Hisham A, Hussein, Zahir S, Yassin, Ahmed K, Jalal, Sana D, Mohammed, Rebar N, Alwan, Alaa F
Publicado 2020

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

por Mardi, Amirhossein, Shirokova, Anastasia V., Mohammed, Rebar N., Keshavarz, Ali, Zekiy, Angelina O., Thangavelu, Lakshmi, Mohamad, Talar Ahmad Merza, Marofi, Faroogh, Shomali, Navid, Zamani, Amir, Akbari, Morteza
Publicado 2022

Anastasis: cell recovery mechanisms and potential role in cancer

por Mohammed, Rebar N., Khosravi, Mohsen, Rahman, Heshu Sulaiman, Adili, Ali, Kamali, Navid, Soloshenkov, Pavel Petrovich, Thangavelu, Lakshmi, Saeedi, Hossein, Shomali, Navid, Tamjidifar, Rozita, Isazadeh, Alireza, Aslaminabad, Ramin, Akbari, Morteza
Publicado 2022

Correction: Anastasis: cell recovery mechanisms and potential role in cancer

por Mohammed, Rebar N., Khosravi, Mohsen, Rahman, Heshu Sulaiman, Adili, Ali, Kamali, Navid, Soloshenkov, Pavel Petrovich, Thangavelu, Lakshmi, Saeedi, Hossein, Shomali, Navid, Tamjidifar, Rozita, Isazadeh, Alireza, Aslaminabad, Ramin, Akbari, Morteza
Publicado 2022

L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy

por Watson, H. Angharad, Durairaj, Ruban R. P., Ohme, Julia, Alatsatianos, Markella, Almutairi, Hanan, Mohammed, Rebar N., Vigar, Miriam, Reed, Sophie G., Paisey, Stephen J., Marshall, Christopher, Gallimore, Awen, Ager, Ann
Publicado 2019

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

por Mohammed, Rebar N., Tamjidifar, Rozita, Rahman, Heshu Sulaiman, Adili, Ali, Ghoreishizadeh, Shadi, Saeedi, Hossein, Thangavelu, Lakshmi, Shomali, Navid, Aslaminabad, Ramin, Marofi, Faroogh, Tahavvori, Mina, Danishna, Svetlana, Akbari, Morteza, Ercan, Gülinnaz
Publicado 2022

Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

por Mohammed, Rebar N., Tamjidifar, Rozita, Rahman, Heshu Sulaiman, Adili, Ali, Ghoreishizadeh, Shadi, Saeedi, Hossein, Thangavelu, Lakshmi, Shomali, Navid, Aslaminabad, Ramin, Marofi, Faroogh, Tahavvori, Mina, Danishna, Svetlana, Akbari, Morteza, Ercan, Gülinnaz
Publicado 2022

Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

por Mohammed, Rebar N., Tamjidifar, Rozita, Rahman, Heshu Sulaiman, Adili, Ali, Ghoreishizadeh, Shadi, Saeedi, Hossein, Thangavelu, Lakshmi, Shomali, Navid, Aslaminabad, Ramin, Marof, Faroogh, Tahavvori, Mina, Danshina, Svetlana, Akbari, Morteza, Ercan, Gülinnaz
Publicado 2022

Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1

por Watson, H Angharad, Dolton, Garry, Ohme, Julia, Ladell, Kristin, Vigar, Miriam, Wehenkel, Sophie, Hindley, James, Mohammed, Rebar N, Miners, Kelly, Luckwell, Rhys A, Price, David A, Matthews, R James, Ager, Ann
Publicado 2016

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

por Marofi, Faroogh, Tahmasebi, Safa, Rahman, Heshu Sulaiman, Kaigorodov, Denis, Markov, Alexander, Yumashev, Alexei Valerievich, Shomali, Navid, Chartrand, Max Stanley, Pathak, Yashwant, Mohammed, Rebar N., Jarahian, Mostafa, Motavalli, Roza, Motavalli Khiavi, Farhad
Publicado 2021

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

por Marofi, Faroogh, Tahmasebi, Safa, Rahman, Heshu Sulaiman, Kaigorodov, Denis, Markov, Alexander, Yumashev, Alexei Valerievich, Shomali, Navid, Chartrand, Max Stanley, Pathak, Yashwant, Mohammed, Rebar N., Jarahian, Mostafa, Motavalli, Roza, Khiavi, Farhad Motavalli
Publicado 2021

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

por Marofi, Faroogh, Rahman, Heshu Sulaiman, Thangavelu, Lakshmi, Dorofeev, Aleksey, Bayas-Morejón, Favian, Shirafkan, Naghmeh, Shomali, Navid, Chartrand, Max Stanley, Jarahian, Mostafa, Vahedi, Ghasem, Mohammed, Rebar N., Shahrokh, Somayeh, Akbari, Morteza, Khiavi, Farhad Motavalli
Publicado 2021

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

por Naimi, Adel, Mohammed, Rebar N., Raji, Ahmed, Chupradit, Supat, Yumashev, Alexei Valerievich, Suksatan, Wanich, Shalaby, Mohammed Nader, Thangavelu, Lakshmi, Kamrava, Siavash, Shomali, Navid, Sohrabi, Armin D., Adili, Ali, Noroozi-Aghideh, Ali, Razeghian, Ehsan
Publicado 2022

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

por Mohammed, Rebar N., Wehenkel, Sophie C., Galkina, Elena V., Yates, Emma-Kate, Preece, Graham, Newman, Andrew, Watson, H. Angharad, Ohme, Julia, Bridgeman, John S., Durairaj, Ruban R. P., Moon, Owen R., Ladell, Kristin, Miners, Kelly L., Dolton, Garry, Troeberg, Linda, Kashiwagi, Masahide, Murphy, Gillian, Nagase, Hideaki, Price, David A., Matthews, R. James, Knäuper, Vera, Ager, Ann
Publicado 2019